Plain-English translation of NCT07660029 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing BloodTrackR, a new device that lets you collect your own blood samples at home using a mobile app to track them. The study aims to see how easy and reliable the device is for people with rheumatoid arthritis, and to compare results from home samples with traditional blood tests taken at a clinic. This could eventually reduce the need for frequent hospital visits while keeping your disease under control.
People with rheumatoid arthritis need frequent blood tests to monitor inflammation and adjust treatment, but traveling to clinics for blood draws is inconvenient and stressful. This medication could help patients collect samples safely at home, reduce pressure on healthcare staff, and allow doctors to catch disease flares earlier by adjusting treatment faster.
You likely qualify if…
You likely don't qualify if…
You would use the BloodTrackR device to collect a blood sample at home following the app's instructions, then have a traditional blood draw done at the same time so researchers can compare the results. You would also answer questions about how easy the device was to use and share your thoughts in interviews about your experience with the new technology.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United Kingdom
Collaborators
National Institute for Health Research, United Kingdom
Enrollment target
~20 participants
Started
June 2026
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jency Rajan
Ulster University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.